Search

everythinglearnresearchcommunity

for

Search:↓

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride reduces hair growth and is safe for women with excessive hair.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

New tests detect finasteride and dutasteride in urine quickly and easily.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Finasteride lowers DHT levels and raises testosterone in a dose-dependent way.

Finasteride may increase depression by reducing brain cell growth.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Post-finasteride syndrome's existence is uncertain; more research needed.

Spironolactone most effective for hirsutism, but has side effects.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Women with effluvium have higher levels of certain urinary steroids, possibly due to stress and increased adrenal activity.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Mitotane changes steroid breakdown, affecting cortisol availability.